共 94 条
[1]
Dalakas MC(2020)Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications Acta Myol 39 289-301
[2]
Zhang L(2012)Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review Clin Cardiol 35 686-691
[3]
Wang GC(2004)Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases Medicine (Baltimore) 83 35-42
[4]
Ma L(1991)A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups Medicine (Baltimore) 7 360-374
[5]
Dankó K(2004)Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy Arthritis Rheum 50 209-215
[6]
Ponyi A(2014)Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis of observational studies Semin Arthritis Rheum 44 63-67
[7]
Constantin T(2015)Cardiac troponin testing in idiopathic inflammatory myopathies and systemic sclerosis-spectrum disorders: biomarkers to distinguish between primary cardiac involvement and low-grade skeletal muscle disease activity Ann Rheum Dis 74 795-798
[8]
Love LA(2001)Cardiac troponin and beta-type myosin heavy chain concentrations in patients with polymyositis or dermatomyositis Clin Chim Acta 306 27-33
[9]
Leff RL(2016)Cardiac abnormalities in adult patients with polymyositis or dermatomyositis as assessed by noninvasive modalities Arthritis Care Res (Hoboken) 68 1012-1020
[10]
Fraser DD(2013)Left ventricular diastolic dysfunction—early cardiac impairment in patients with polymyositis/dermatomyositis: a tissue Doppler imaging study J Rheumatol 40 1572-1577